Premium
Preservation of fertility in females with haematological malignancy
Author(s) -
Donnez Jacques,
Dolmans MarieMadeleine
Publication year - 2011
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2011.08723.x
Subject(s) - fertility preservation , ovarian tissue cryopreservation , cryopreservation , oocyte cryopreservation , fertility , embryo cryopreservation , malignancy , medicine , chemotherapy , gynecology , oncology , embryo , biology , andrology , population , environmental health , microbiology and biotechnology
Summary Several options are currently available for the preservation of fertility in cancer patients: embryo cryopreservation, oocyte cryopreservation or ovarian tissue cryopreservation. The choice of the most suitable strategy for preserving fertility depends on different parameters: the type and timing of chemotherapy, the type of cancer, the patient’s age and the partner status. Cryopreservation of ovarian tissue is the only option available for prepubertal girls and woman who cannot delay the start of chemotherapy. So far, 15 live births have been obtained after orthotopic transplantation of cryopreserved ovarian tissue.